Prezzo di chiusura
Altri mercati azionari
|
||
- USD | - |
|
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Paolo Manfredi
FOU | Founder | 62 | 31/05/12 |
Sergio Traversa
CEO | Chief Executive Officer | 63 | - |
Maged Shenouda
DFI | Director of Finance/CFO | 59 | 12/11/15 |
Charles Ence
CMP | Compliance Officer | 64 | 29/07/19 |
John Hixon
PRN | Corporate Officer/Principal | - | 21/07/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Chairman | 78 | 14/07/15 | |
Sergio Traversa
CEO | Chief Executive Officer | 63 | - |
Maged Shenouda
DFI | Director of Finance/CFO | 59 | 12/11/15 |
Fabiana Fedeli
BRD | Director/Board Member | 53 | 12/01/23 |
Director/Board Member | 61 | 19/12/19 | |
Paul Kelly
BRD | Director/Board Member | 65 | 12/11/15 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 30 174 202 | 27 748 959 ( 91,96 %) | 0 | 91,96 % |
Coordinate società
Relmada Therapeutics, Inc.
2222 Ponce de Leon Boulevard 3rd floor
33134, Coral Gables
+786-629-1376
http://www.relmada.com![Indirizzo Relmada Therapeutics Inc](https://cdn.zonebourse.com/static/address/23746655.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+20,17% | 126 Mrd | |
+24,67% | 118 Mrd | |
+23,52% | 27,87 Mrd | |
-17,74% | 20,95 Mrd | |
-15,99% | 16,92 Mrd | |
-15,21% | 16,18 Mrd | |
+11,91% | 14,84 Mrd | |
-47,10% | 14,79 Mrd | |
+54,50% | 14,08 Mrd |
- Borsa valori
- Azioni
- Azione RLMD
- Azione
- Società Relmada Therapeutics Inc